Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report

Background: The patients with coronavirus disease 2019 (COVID-19) associated with severe acute respiratory distress syndrome (ARDS) may require prolonged mechanical ventilation which often results in lung fibrosis, thus worsening the prognosis and increasing fatality rates. A mesenchymal stromal cel...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kátia Nunes da Silva, Priscila Carvalho Guedes Pinheiro, André Luiz Nunes Gobatto, Rogério da Hora Passos, Bruno Diaz Paredes, Luciana Souza de Aragão França, Carolina Kymie Vasques Nonaka, Beatriz Barreto-Duarte, Mariana Araújo-Pereira, Rafael Tibúrcio, Fernanda Ferreira Cruz, Gabriele Louise Soares Martins, Bruno B. Andrade, Hugo Caire de Castro-Faria-Neto, Patricia Rieken Macêdo Rocco, Bruno Solano de Freitas Souza
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	COVID-19 ARDS mesenchymal stromal cells (MSCs) cell therapy immunomodulation fibrosis Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/aacbb0f219764d21b36c2ccb79f166fd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report

Ejemplares similares